Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study (Q33329758)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study
scientific article

    Statements

    Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit